Health Care
Commentary
Learn more about how price controls are driving physician shortages
Price Controls Are Harming Doctors
Whether its pharmaceuticals or health insurance, Vice President Kamala Harris appears to have only one healthcare policy – impose price controls. The untenable financial position of many doctors and private doctor practices due to tightening Medicare reimbursement rates exemplifies the folly of her preferred approach. As I document in a recent ...
Commentary
Learn how Vance's suggestion would benefit consumers
Vance’s Argument on Preexisting Conditions a Sure Winner
When asked how people with pre-existing conditions would fare under a Trump-Vance administration during last week’s vice-presidential debate, Sen. J.D. Vance, R-Ohio, was unequivocal. “Well, of course, we’re going to cover Americans with pre-existing conditions.” The question was prompted by Vance’s statement last month that the Republican ticket would consider creating different risk ...
340B. drug pricing
How The Hospital Industrial Complex Robs Poor Patients
Pharmaceutical leader Johnson & Johnson recently unleashed a firestorm in Washington after it proposed a change to how it offers discounted prices on two drugs in a little-known, but enormous, federal program that’s hurting the low-income patients it was created to help. That program, known as the “340B Drug Pricing Program,” allows ...
Commentary
Harris’s Farcical Price Control Schemes
Karl Marx famously said that history repeats itself first as tragedy, then as farce. Vice President Kamala Harris is bringing that aphorism to life by putting price controls at the center of her economic agenda. Despite centuries of evidence that such controls invariably lead to shortages, rationing and general economic ...
Commentary
American Healthcare Broken? Says Who?
A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
Biosimilars
The Biosimilar Promise
Biosimilars Often Reduce Prices by 50 Percent or More
Biosimilars Often Reduce Prices by 50 Percent or More By Wayne Winegarden | October 1, 2024 READ PDF Executive Summary In the competitive biologic markets, biosimilars have reduced average prices by 56 percent. The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though ...
Commentary
A British Lord’s Warning: Steer Clear of Single-Payer Healthcare
Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Commentary
Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion
Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Climate Change
Learn how municipal climate change lawsuits hurt consumers
Bonta’s legal war on energy companies will punish ordinary Californians
Neither are heroic efforts to safeguard the environment. The former will primarily harm families by worsening the nation’s pervasive affordability problems. The second is a clear effort to extract “multiple billions” from ExxonMobil while maximizing political optics in a state where the majority of voters will support anything they are ...
Commentary
Learn how PBMs pocket savings intended for patients
How Long Can Pharmacy Benefit Managers Go Unchecked?
Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
Learn more about how price controls are driving physician shortages
Price Controls Are Harming Doctors
Whether its pharmaceuticals or health insurance, Vice President Kamala Harris appears to have only one healthcare policy – impose price controls. The untenable financial position of many doctors and private doctor practices due to tightening Medicare reimbursement rates exemplifies the folly of her preferred approach. As I document in a recent ...
Learn how Vance's suggestion would benefit consumers
Vance’s Argument on Preexisting Conditions a Sure Winner
When asked how people with pre-existing conditions would fare under a Trump-Vance administration during last week’s vice-presidential debate, Sen. J.D. Vance, R-Ohio, was unequivocal. “Well, of course, we’re going to cover Americans with pre-existing conditions.” The question was prompted by Vance’s statement last month that the Republican ticket would consider creating different risk ...
How The Hospital Industrial Complex Robs Poor Patients
Pharmaceutical leader Johnson & Johnson recently unleashed a firestorm in Washington after it proposed a change to how it offers discounted prices on two drugs in a little-known, but enormous, federal program that’s hurting the low-income patients it was created to help. That program, known as the “340B Drug Pricing Program,” allows ...
Harris’s Farcical Price Control Schemes
Karl Marx famously said that history repeats itself first as tragedy, then as farce. Vice President Kamala Harris is bringing that aphorism to life by putting price controls at the center of her economic agenda. Despite centuries of evidence that such controls invariably lead to shortages, rationing and general economic ...
American Healthcare Broken? Says Who?
A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
The Biosimilar Promise
Biosimilars Often Reduce Prices by 50 Percent or More
Biosimilars Often Reduce Prices by 50 Percent or More By Wayne Winegarden | October 1, 2024 READ PDF Executive Summary In the competitive biologic markets, biosimilars have reduced average prices by 56 percent. The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though ...
A British Lord’s Warning: Steer Clear of Single-Payer Healthcare
Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion
Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Learn how municipal climate change lawsuits hurt consumers
Bonta’s legal war on energy companies will punish ordinary Californians
Neither are heroic efforts to safeguard the environment. The former will primarily harm families by worsening the nation’s pervasive affordability problems. The second is a clear effort to extract “multiple billions” from ExxonMobil while maximizing political optics in a state where the majority of voters will support anything they are ...
Learn how PBMs pocket savings intended for patients
How Long Can Pharmacy Benefit Managers Go Unchecked?
Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
